GSK PLC ADR (GSK) Social Stream



GSK PLC ADR (GSK): $36.25

0.09 (-0.25%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

GSK PLC (GSK) Price Targets From Analysts

Use the tables below to see what analysts covering GSK PLC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 8 $52.5 $41.5 $47.75 $36.34 31.4%
2022-01-03 8 $51 $41.5 $47.375 $36.34 30.37%
2022-01-17 7 $51 $44.2 $48.733 $36.34 34.1%
2022-02-02 7 $52.5 $44.2 $49.233 $36.34 35.48%
2022-02-14 7 $52.5 $46.3 $49.933 $36.34 37.41%
2022-03-14 7 $51.5 $45.6 $49.366 $36.34 35.84%
2022-04-05 7 $55 $45.6 $50.533 $36.34 39.06%
2022-04-19 7 $55 $45.7 $50.566 $36.34 39.15%
2022-04-21 7 $55 $44.5 $50.166 $36.34 38.05%
2022-04-27 7 $55 $45.9 $50.633 $36.34 39.33%
2022-05-31 6 $52.5 $45.9 $49.8 $36.34 37.04%
2022-06-07 7 $52.5 $45.9 $49.8 $36.34 37.04%
2022-06-16 7 $51 $45.9 $49.133 $36.34 35.2%
2022-07-26 7 $63.125 $44.4 $52.841 $36.34 45.41%
2022-08-13 7 $63.125 $43.5 $52.541 $36.34 44.58%
2022-08-24 7 $63.125 $36 $50.041 $36.34 37.7%
2022-09-19 7 $51 $34 $40.333 $36.34 10.99%
2022-10-21 7 $51 $33 $40 $36.34 10.07%
2022-11-01 7 $51 $33 $40.666 $36.34 11.9%
2022-11-23 7 $51 $33 $40.666 $36.34 11.9%
2022-12-04 7 $51 $33 $40.666 $36.34 11.9%
2022-12-05 7 $51 $33 $39.833 $36.34 9.61%
2022-12-07 7 $51 $33 $40.066 $36.34 10.25%
2023-02-01 7 $51 $36.2 $41.733 $36.34 14.84%
2023-04-20 7 $51 $35.5 $41.5 $36.34 14.2%
2023-04-27 7 $51 $36 $42 $36.34 15.58%
2023-07-05 7 $45 $36 $40 $36.34 10.07%
2023-07-17 7 $45 $35 $39.666 $36.34 9.15%
2023-09-12 6 $45 $35 $39.833 $36.34 9.61%
2023-09-22 7 $45 $35 $39.833 $36.34 9.61%

The Trend in the Analyst Price Target


Over the past 40 months, GSK's average price target has gone down $7.32.

GSK reports an average of 16.7% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-16 7 51 33.0 40.666 32.91 23.57%
2023-01-24 7 51 36.2 41.733 34.70 20.27%
2023-02-03 7 51 35.5 41.500 34.83 19.15%
2023-04-20 7 51 35.5 41.833 36.46 14.74%
2023-09-11 6 45 35.0 39.833 37.02 7.6%

GSK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.71 0 0 4 2 2 7

The Trend in the Broker Recommendations


Over the past 19 months, GSK's average broker recommendation rating worsened by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of stocks in the large market cap category, GSK PLC's number of analysts covering the stock is higher than 349.84% of them.
  • GSK PLC's variance in analysts' estimates is lower than -419.26% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, GSK PLC's upside potential (average analyst target price relative to current price) is higher than 581.12% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, GSK PLC's average analyst price target is greater than 857.48% of them.

In the Pharmaceutical Products industry, GRFS, SNY, and GLPG are the three stocks most similar to GSK PLC regarding the price target and analyst recommendation information presented here.

Is GSK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!